Internal Medicine, Rheumatology · Greensboro, NC
NPI
1124206388
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2835 Horse Pen Creek Rd, Suite 101
Greensboro, NC, 27410
Phone (336) 617-6568
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
238,810 services
Medicare patients, 2024
372
Average age 75
Drug cost, 2024
$3.0M
4,076 prescriptions
Company payments, 2025
$3,112
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Angela Hawkes was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 90,000 times for 33 patients. In total Angela Hawkes billed 238,810 services in 45 codes, and Medicare paid $2.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-08-03.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 90,000 | 33 | $3.61 | $324K |
| J3262 Injection, tocilizumab, 1 mg | Office | 60,360 | 18 | $4.71 | $284K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 53,308 | 79 | $8.98 | $478K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 13,290 | 46 | $24.69 | $328K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 10,225 | 33 | $33.83 | $346K |
| J0897 Injection, denosumab, 1 mg | Office | 2,940 | 30 | $20.26 | $60K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 1,042 | 11 | $0.10 | $109 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 482 | 243 | $11.29 | $5,442 |
| 99214 Office E&M - Established | Office | 441 | 236 | $85.60 | $38K |
| 96401 Chemotherapy Administration | Office | 426 | 32 | $51.95 | $22K |
| 96365 Intravenous Infusion, Hydration | Office | 418 | 116 | $45.35 | $19K |
| 96413 Chemotherapy Administration | Office | 333 | 76 | $92.88 | $31K |
| 96415 Chemotherapy Administration | Office | 227 | 51 | $20.07 | $4,556 |
| 96372 Injection Administration | Office | 111 | 48 | $10.02 | $1,112 |
| 99213 Office E&M - Established | Office | 50 | 44 | $55.29 | $2,764 |
By year: 2022 $2.4M for 228,986 services; 2023 $2.4M for 265,022 services; 2024 $2.1M for 238,810 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 66 | 62 | $2.95 | $195 |
Medicare prescription drug claims, 2024
In 2024, the drug Angela Hawkes prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 893 prescriptions and refills. In total Angela Hawkes wrote 4,076 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 893 | 1,899 | 214 | $35K |
| Methotrexate Methotrexate Sodium | 851 | 1,602 | 181 | $17K |
| Prednisone Generic | 538 | 864 | 144 | $3,502 |
| Leflunomide Generic | 237 | 522 | 66 | $14K |
| Meloxicam Generic | 187 | 399 | 45 | $1,008 |
| Allopurinol Generic | 187 | 495 | 50 | $2,258 |
| Folic Acid Generic | 117 | 277 | 30 | $1,214 |
| Enbrel Sureclick Etanercept | 97 | 97 | 11 | $742K |
| Diclofenac Sodium Generic | 96 | 169 | 26 | $1,793 |
| Celecoxib Generic | 95 | 201 | 26 | $2,390 |
| Humira(Cf) Pen Adalimumab | 91 | 91 | Under 11 | $860K |
| Colchicine Generic | 50 | 66 | 16 | $4,928 |
| Rinvoq Upadacitinib | 46 | 46 | Under 11 | $294K |
| Methotrexate Sodium Methotrexate Sodium/Pf | 45 | 92 | 20 | $908 |
| Gabapentin Generic | 44 | 54 | 13 | $357 |
Brand drugs: - claims; generic drugs: 3,523 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angela Hawkes $3,112 ($3,112 in general payments such as food, travel and fees) from 23 companies. The largest payer was Amgen Inc. with $628.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 39 | $628 |
| Abbvie Inc. ABBV | 25 | $407 |
| UCB, Inc. UCB.BR | 22 | $367 |
| Janssen Biotech, Inc. JNJ | 15 | $280 |
| Pfizer Inc. PFE | 14 | $259 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $250 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $130 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $93.75 |
| Genentech USA, Inc. ROG.SW | 4 | $81.26 |
| Genzyme Corporation SNY | 3 | $80.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.